Results 61 to 70 of about 1,137 (206)

Commercially Available Cell-Free Permeability Tests for Industrial Drug Development: Increased Sustainability through Reduction of In Vivo Studies

open access: yesPharmaceutics, 2023
Replacing in vivo with in vitro studies can increase sustainability in the development of medicines. This principle has already been applied in the biowaiver approach based on the biopharmaceutical classification system, BCS.
Ann-Christin Jacobsen   +4 more
doaj   +1 more source

Evaluation of Differences in Dosage Form Performance of Generics Using BCS-Based Biowaiver Specifications and Biopharmaceutical Modeling

open access: yes, 2022
S.2437-2453Drug products containing the antibiotics amoxicillin (500 mg as trihydrate) or doxycycline (200 mg as hyclate or monohydrate) with varying qualitative excipient composition were obtained from the German market and their biopharmaceutical ...
Hofsäss, M.A., Dressman, J.
core   +1 more source

Effects of experimental conditions on solubility measurements for BCS classification in order to improve the biowaiver guidelines

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2021
Among the methods described for determining the solubility, shake-flask is suitable to evaluate the equilibrium solubility according to the BCS. Nevertheless, experimental conditions related to the shake-flask method are not well described.
Patrícia Fernanda Monteiro   +5 more
doaj   +1 more source

Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging Trends

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 43-54, July 2026.
Human radiolabeled mass balance studies are crucial for comprehensively characterizing the absorption, distribution, metabolism, and excretion (ADME) of investigational drugs, providing essential data for drug development, regulatory evaluation, and product labeling.
Jason Boer   +24 more
wiley   +1 more source

In Silico Prediction of Plasma Concentrations of Fluconazole Capsules with Different Dissolution Profiles and Bioequivalence Study Using Population Simulation

open access: yesPharmaceutics, 2019
A biowaiver is accepted by the Brazilian Health Surveillance Agency (ANVISA) for immediate-release solid oral products containing Biopharmaceutics Classification System (BCS) class I drugs showing rapid drug dissolution.
Marcelo Dutra Duque   +5 more
doaj   +1 more source

Types of Biowaivers: A Discussion

open access: yesInternational Journal of Drug Regulatory Affairs, 2019
The aim of the present review is to discuss the different types of biowaiver applications. Waiving of In vivo bioequivalence studies is known as biowaiver. Types of biowaiver applications include BCS based biowaiver, well established use application, also known as bibliographical application and Literature based submission.
openaire   +1 more source

Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 7, July 2026.
ABSTRACT Physiologically based pharmacokinetic (PBPK) modeling is a mechanistic cornerstone of model‐informed drug development (MIDD), providing evidence for regulatory decisions. PBPK models integrate physiological and pharmacological data and have been applied across a plethora of contexts of use, including assessing drug–drug interactions (DDIs ...
Marylore Chenel   +6 more
wiley   +1 more source

Scientific Opinion on waiving of the dog studies in the regulatory process of agrochemicals approval

open access: yesEFSA Journal, Volume 24, Issue 7, July 2026.
Abstract Commission Regulation (EU) No. 283/2013 sets out the data requirements for pesticide active substances and includes short‐term oral toxicity testing in rodents (90‐day rat study) and non‐rodents (90‐day dog study) to support human health hazard assessment for pesticide active substances in the European Union (EU). However, the relevance of the
EFSA Panel on Plant Protection Products and their Residues (PPR)   +20 more
wiley   +1 more source

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Moxifloxacin Hydrochloride

open access: yes, 2022
S.2654-2675In this monograph, literature data is reviewed to evaluate the feasibility of waiving in vivo bioequivalence testing and instead applying the Biopharmaceutics Classification System (BCS) based methods to the approval of immediate-release solid
Mehta, M.   +12 more
core   +1 more source

Justification of metformin hydrochloride biowaiver criteria based on bioequivalence study

open access: yes, 2010
The Biopharmaceutics Classification System (BCS) represents the framework for predicting the intestinal drug absorption based on its solubility and intestinal permeability. Recent research has lead to the use of in vitro tests to waive additional in vivo
Homšek, Irena   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy